1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders
(
- Contribution to journal › Scientific review
- 2015
-
Mark
URB937, a peripherally-restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano-afferent nerve fibers in rats.
2015) In BJU International(
- Contribution to journal › Article